Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Michel

Showing results (171-180 of 1,656) with videos related to

Pageof 166
Sort By:
The Journal of Physiology|December 22, 1999
Flow modulates the transport of K+ through the walls of single perfused mesenteric venules in anaesthetised ratsM Kajimura, C C Michel
British Journal of Clinical Pharmacology|September 19, 2001
The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockersV Limmroth, M C Michel
World Journal of Urology|March 2, 2011
What do we really know about benign prostatic hyperplasia and lower urinary tract symptoms in adult men?Matthias Oelke, Martin C Michel
Women'S Health (London, England)|October 7, 2009
Duloxetine in the treatment of stress urinary incontinenceMartin C Michel, Matthias Oelke
British Journal of Clinical Pharmacology|January 17, 2012
Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTsKoenraad Blot, Martin C Michel
Experientia|January 15, 1978
Induction of developmental anomalies in mice by maternal stressC Michel, H Fritz-Niggli
Trends in Pharmacological Sciences|October 1, 1992
Keeping an eye on the I site: imidazoline-preferring receptorsM C Michel, P Ernsberger
Pharmacological Reviews|December 17, 2008
Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicineDieter Rosskopf, Martin C Michel
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 11, 2007
Tools to study beta3-adrenoceptorsWim Vrydag, Martin C Michel
Molecular Pharmacology|June 28, 2005
Can a GDP-liganded G-protein be active?Thomas Wieland, Martin C Michel
Pageof 166

Showing results (171-180 of 1,656) with videos related to

Sort By:
Pageof 166
The Journal of Physiology|December 22, 1999
Flow modulates the transport of K+ through the walls of single perfused mesenteric venules in anaesthetised ratsM Kajimura, C C Michel
British Journal of Clinical Pharmacology|September 19, 2001
The prevention of migraine: a critical review with special emphasis on beta-adrenoceptor blockersV Limmroth, M C Michel
World Journal of Urology|March 2, 2011
What do we really know about benign prostatic hyperplasia and lower urinary tract symptoms in adult men?Matthias Oelke, Martin C Michel
Women'S Health (London, England)|October 7, 2009
Duloxetine in the treatment of stress urinary incontinenceMartin C Michel, Matthias Oelke
British Journal of Clinical Pharmacology|January 17, 2012
Authors' response to Hermann et al. Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from RCTsKoenraad Blot, Martin C Michel
Experientia|January 15, 1978
Induction of developmental anomalies in mice by maternal stressC Michel, H Fritz-Niggli
Trends in Pharmacological Sciences|October 1, 1992
Keeping an eye on the I site: imidazoline-preferring receptorsM C Michel, P Ernsberger
Pharmacological Reviews|December 17, 2008
Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicineDieter Rosskopf, Martin C Michel
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 11, 2007
Tools to study beta3-adrenoceptorsWim Vrydag, Martin C Michel
Molecular Pharmacology|June 28, 2005
Can a GDP-liganded G-protein be active?Thomas Wieland, Martin C Michel
Pageof 166